1. Home
  2. NMIH vs IDYA Comparison

NMIH vs IDYA Comparison

Compare NMIH & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NMI Holdings Inc.

NMIH

NMI Holdings Inc.

HOLD

Current Price

$37.79

Market Cap

2.9B

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$35.70

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMIH
IDYA
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.9B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
NMIH
IDYA
Price
$37.79
$35.70
Analyst Decision
Buy
Strong Buy
Analyst Count
5
14
Target Price
$42.60
$49.33
AVG Volume (30 Days)
425.6K
964.1K
Earning Date
02-10-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
9.56
N/A
EPS
4.79
N/A
Revenue
$692,208,000.00
$214,834,000.00
Revenue This Year
N/A
$2,688.43
Revenue Next Year
$4.79
N/A
P/E Ratio
$7.94
N/A
Revenue Growth
8.86
5377.66
52 Week Low
$31.90
$13.45
52 Week High
$43.20
$39.28

Technical Indicators

Market Signals
Indicator
NMIH
IDYA
Relative Strength Index (RSI) 39.72 51.98
Support Level $35.74 $34.75
Resistance Level $41.00 $37.81
Average True Range (ATR) 1.00 1.71
MACD -0.52 -0.05
Stochastic Oscillator 33.11 46.79

Price Performance

Historical Comparison
NMIH
IDYA

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: